Drug Type Antibody fusion proteins |
Synonyms- |
Target |
Action modulators |
Mechanism SMOC1 modulators(SPARC related modular calcium binding 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | Australia | 02 Sep 2020 |